Publications

Posters and Presentations

11/17/2022

Two Randomized, Double-Blind, Placebo-Controlled Trials of Adjunctive Troriluzole, a Novel Glutamate-Modulating Agent, in Obsessive-Compulsive Disorder

03/13/2023

Discovery and Characterization of BHV-7000: A Novel Kv7.2/7.3 Activator for the Treatment of Epilepsy

12/03/2022

Effects of retigabine and the novel M-current activator BHV-7000 on epilepsy-associated KCNQ2 variants

03/20/2023

Taldefgrobep Alfa: Preclinical and Clinical Data Supporting the Phase 3 RESILIENT Study in Spinal Muscular Atrophy